Company Search:
Advanced Search
Sponsored Links
Summit Therapeutics PLC Company Snapshot
Summit Therapeutics PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Summit Therapeutics PLC with three other companies in this sector in the United Kingdom: Collagen Solutions PLC (2017 sales of £3.95 million [US$5.44 million] ), Premier Veterinary Group PLC (£2.53 million [US$3.50 million] ), and Angle PLC (£498,000.00 [US$686,896.38 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Summit Therapeutics PLC
  Stock Performance Chart for Summit Therapeutics PLC
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 190.00p
(Figures in Pounds Sterling)
1 Week 10.1%   13 Weeks 16.9%  
4 Weeks -1.3%   52 Weeks 20.6%  
Summit Therapeutics PLC Key Data:
  Ticker: SUMM Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,304,000
(Year Ending Jan 2018).
Employees: 44
  Currency: Pounds Sterling Market Cap: 134,195,769
  Fiscal Yr Ends: January Shares Outstanding: 70,629,352
  Share Type: Ordinary Closely Held Shares: 5,714,724
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.